BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mora-Ramirez E, Santoro L, Cassol E, Ocampo-Ramos JC, Clayton N, Kayal G, Chouaf S, Trauchessec D, Pouget JP, Kotzki PO, Deshayes E, Bardiès M. Comparison of commercial dosimetric software platforms in patients treated with 177 Lu-DOTATATE for peptide receptor radionuclide therapy. Med Phys 2020;47:4602-15. [PMID: 32632928 DOI: 10.1002/mp.14375] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Mok GSP, Dewaraja YK. Recent advances in voxel-based targeted radionuclide therapy dosimetry. Quant Imaging Med Surg 2021;11:483-9. [PMID: 33532249 DOI: 10.21037/qims-20-1006] [Reference Citation Analysis]
2 Uribe C, Peterson A, Van B, Fedrigo R, Carlson J, Sunderland J, Frey E, Dewaraja YK. An International Study of Factors Affecting Variability of Dosimetry Calculations, Part 1: Design and Early Results of the SNMMI Dosimetry Challenge. J Nucl Med 2021;62:36S-47S. [PMID: 34857620 DOI: 10.2967/jnumed.121.262748] [Reference Citation Analysis]
3 Brosch-Lenz J, Uribe C, Gosewisch A, Kaiser L, Todica A, Ilhan H, Gildehaus FJ, Bartenstein P, Rahmim A, Celler A, Ziegler S, Böning G. Influence of dosimetry method on bone lesion absorbed dose estimates in PSMA therapy: application to mCRPC patients receiving Lu-177-PSMA-I&T. EJNMMI Phys 2021;8:26. [PMID: 33709253 DOI: 10.1186/s40658-021-00369-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bardiès M, Gear JI. Scientific Developments in Imaging and Dosimetry for Molecular Radiotherapy. Clin Oncol (R Coll Radiol) 2021;33:117-24. [PMID: 33281018 DOI: 10.1016/j.clon.2020.11.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kayal G, Clayton N, Vergara-Gil A, Struelens L, Bardiès M. Proof-of-concept of DosiTest: A virtual multicentric clinical trial for assessing uncertainties in molecular radiotherapy dosimetry. Phys Med 2022;97:25-35. [PMID: 35339863 DOI: 10.1016/j.ejmp.2022.03.011] [Reference Citation Analysis]
6 Kayal G, Chauvin M, Vergara-Gil A, Clayton N, Ferrer L, Moalosi T, Knoll P, Struelens L, Bardiès M. Generation of clinical 177Lu SPECT/CT images based on Monte Carlo simulation with GATE. Phys Med 2021;85:24-31. [PMID: 33957577 DOI: 10.1016/j.ejmp.2021.04.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Carter LM, Ocampo Ramos JC, Kesner AL. Personalized dosimetry of177Lu-DOTATATE: a comparison of organ- and voxel-level approaches using open-access images. Biomed Phys Eng Express 2021;7. [PMID: 34271565 DOI: 10.1088/2057-1976/ac1550] [Reference Citation Analysis]
8 Wahl RL, Sunderland J. Radiopharmaceutical Dosimetry for Cancer Therapy: From Theory to Practice. J Nucl Med 2021;62:1S-2S. [PMID: 34857618 DOI: 10.2967/jnumed.121.263273] [Reference Citation Analysis]
9 Bos-Liedke A, Cegla P, Matuszewski K, Konstanty E, Piotrowski A, Gross M, Malicki J, Kozak M. Differences among [18F]FDG PET-derived parameters in lung cancer produced by three software packages. Sci Rep 2021;11:13942. [PMID: 34230642 DOI: 10.1038/s41598-021-93436-w] [Reference Citation Analysis]
10 Kennedy J, Chicheportiche A, Keidar Z. Quantitative SPECT/CT for dosimetry of peptide receptor radionuclide therapy. Semin Nucl Med 2021:S0001-2998(21)00091-X. [PMID: 34911637 DOI: 10.1053/j.semnuclmed.2021.11.004] [Reference Citation Analysis]
11 Brosch-Lenz J, Yousefirizi F, Zukotynski K, Beauregard JM, Gaudet V, Saboury B, Rahmim A, Uribe C. Role of Artificial Intelligence in Theranostics:: Toward Routine Personalized Radiopharmaceutical Therapies. PET Clin 2021;16:627-41. [PMID: 34537133 DOI: 10.1016/j.cpet.2021.06.002] [Reference Citation Analysis]
12 Della Gala G, Bardiès M, Tipping J, Strigari L. Overview of commercial treatment planning systems for targeted radionuclide therapy. Phys Med 2021;92:52-61. [PMID: 34864422 DOI: 10.1016/j.ejmp.2021.11.001] [Reference Citation Analysis]
13 Santoro L, Pitalot L, Trauchessec D, Mora-Ramirez E, Kotzki PO, Bardiès M, Deshayes E. Clinical implementation of PLANET® Dose for dosimetric assessment after [177Lu]Lu-DOTA-TATE: comparison with Dosimetry Toolkit® and OLINDA/EXM® V1.0. EJNMMI Res 2021;11:1. [PMID: 33394212 DOI: 10.1186/s13550-020-00737-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
14 Herrmann K, Giovanella L, Santos A, Gear J, Kiratli PO, Kurth J, Denis-bacelar AM, Hustinx R, Patt M, Wahl RL, Paez D, Giammarile F, Jadvar H, Pandit-taskar N, Ghesani M, Kunikowska J. Joint EANM, SNMMI and IAEA enabling guide: how to set up a theranostics centre. Eur J Nucl Med Mol Imaging. [DOI: 10.1007/s00259-022-05785-x] [Reference Citation Analysis]